130 related articles for article (PubMed ID: 32329855)
1. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3786-3794. PubMed ID: 32329855
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
3. VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ.
Liu H; Kong W; Wen S; Wu J; Yin X; Liu Y
J BUON; 2021; 26(4):1563-1570. PubMed ID: 34565020
[TBL] [Abstract][Full Text] [Related]
4. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
6. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
7. VASN promotes proliferation of prostate cancer through the YAP/TAZ axis.
Cui FL; Mahmud AN; Xu ZP; Wang ZY; Hu JP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6589-6596. PubMed ID: 32633347
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prolyl isomerase Pin1 as a novel positive regulator of YAP/TAZ in breast cancer cells.
Khanal P; Yeung B; Zhao Y; Yang X
Sci Rep; 2019 Apr; 9(1):6394. PubMed ID: 31015482
[TBL] [Abstract][Full Text] [Related]
9. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
Wang FH; Ma XJ; Xu D; Luo J
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
[TBL] [Abstract][Full Text] [Related]
10. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
Wang YL; Li Y; Ma YG; Wu WY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.
Fu J; Zheng M; Zhang X; Zhang Y; Chen Y; Li H; Wang X; Zhang J
Biochem Biophys Res Commun; 2017 Nov; 493(2):985-991. PubMed ID: 28942149
[TBL] [Abstract][Full Text] [Related]
12. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.
Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q
PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387
[TBL] [Abstract][Full Text] [Related]
14. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
He SZ; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression.
Zhou T; Fang JJ; Zhou YX; Li ZP; Jiang L; Han WW; Zhu ZH
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1250-1257. PubMed ID: 32096155
[TBL] [Abstract][Full Text] [Related]
17. MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.
Costa V; Carina V; Raimondi L; De Luca A; Bellavia D; Conigliaro A; Salamanna F; Alessandro R; Fini M; Giavaresi G
Cells; 2019 Nov; 8(12):. PubMed ID: 31771093
[TBL] [Abstract][Full Text] [Related]
18. High expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients.
Feng Q; Guo P; Kang S; Zhao F
Pharmazie; 2018 Nov; 73(11):662-665. PubMed ID: 30396386
[No Abstract] [Full Text] [Related]
19. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.
Liu CY; Chan SW; Guo F; Toloczko A; Cui L; Hong W
Oncotarget; 2016 Mar; 7(12):13706-16. PubMed ID: 26885614
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
Que LM; Yang XR; Zhang YC; Zhong H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
